ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1703

Gender Equity in Academic Rheumatology – Is There a Gender Gap at European Rheumatology Congresses?

Neelam Hassan1, Leonieke van Mens2, Uta Kiltz3, Concha Delgado4, Pavel Ovseiko5, Laure Gossec6 and Laura Coates7, 1Musculoskeletal Research Unit, University of Bristol, UK., Bristol, United Kingdom, 2Clinical Immunology & Rheumatology, Amsterdam Rheumatology and immunology Center, Academic Medical Center/University of Amsterdam, amsterdam, Netherlands, 3Rheumazentrum Ruhrgebiet, Ruhr-University Bochum, Herne, Germany, 4Hospital Clínico Universitario Lozano Blesa. Zaragoza., Zaragoza, Spain, 5Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom, 6Sorbonne Université and Hôpital Universitaire Pitié Salpêtrière, Paris, France, 7University of Oxford, Oxford, United Kingdom

Meeting: ACR Convergence 2020

Keywords: education, medical, gender

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2020

Title: Professional Education Poster

Session Type: Poster Session D

Session Time: 9:00AM-11:00AM

Background/Purpose: While increasing numbers of women are choosing rheumatology, they remain underrepresented in academic medicine, particularly in senior leadership roles. The reasons for this are multifactorial but increased visibility of women leaders as role models has been proposed as one of the solutions. National and international academic congresses could promote gender equity among speakers.

In recent American College of Rheumatology (ACR) Annual Meeting, 42.8% of speakers and moderators were women in 2017, versus 47.0% in 2018 (1) and 49.1% in 2019 (personal communication).  Such data were not available in Europe. The purpose of this study, within the remit of the EULAR Gender Equity Taskforce (2), was to describe the proportion of women invited as moderators or speakers to the European League Against Rheumatism (EULAR) Annual Congresses and National Congresses in Europe.

Methods: Using published congress materials, we determined the proportions of women included in the congresses as either moderators or invited speakers, for EULAR (2015-2019) and 2019 national congresses in France, Germany, Italy, Spain and UK.  Individual speakers could be counted multiple times, if they had multiple roles within each congress. For EULAR congresses, we further categorized by Clinical/Science, Health Professionals in Rheumatology (HPR) and People with Arthritis and Rheumatism (PARE) sessions.

Results: The proportion of combined women speakers and moderators at EULAR between 2015 and 2019 varied from 39.7 to 43.2% with no obvious trend over time (Fig 1).  Proportions of women moderators and invited speakers were similar. There were much greater proportions of female speakers in the HPR and PARE sessions (over 50% consistently) but these sessions represent < 30% of the EULAR congress invitations (Fig 1).  Representation of women at national meetings in France and Germany appeared lower than that in Spain, the UK and at EULAR (Fig 2).

Conclusion: Women account for approximately 40% or less of invited moderators and speakers at the European congresses reviewed, whilst many national congresses are lower. A comparison with the available historical data on women moderators at EULAR in 2003 (16%) and in 2004 (19%) indicates formidable change over the last 15 years (3). Yet, our data does not show an improvement in gender equity in recent years at EULAR congresses, as was seen for the ACR meetings. The establishment of the EULAR Task Force on Gender Equity in Academic Rheumatology signals the commitment of EULAR to accelerate the pace of change in Europe.

  • Monga K et al. ARD. 2020; online.
  • Ovseiko P et al. ARD 2020; 79 (supp 1): 527
  • Lundberg IE et al. A&R 2005;52(3):697.

Fig 1: Proportion of women invited to participate in EULAR sessions, by type of session

Figure 2: Proportion of women invited as chairs and Invited Speakers at EULAR and National Congresses in Europe in 2019


Disclosure: N. Hassan, None; L. van Mens, None; U. Kiltz, Abbvie, 2, 5, Biocad, 2, 5, Biogen, 2, 5, Chugai, 2, 5, Eli Lilly, 2, 5, Grünenthal, 2, 5, Janssen, 2, 5, MSD, 2, 5, Novartis, 2, 5, Pfizer, 2, 5, Roche, 2, 5, UCB, 2, 5; C. Delgado, None; P. Ovseiko, None; L. Gossec, Sandoz, 1, AbbVie, 5, 8, Amgen Inc., 5, 8, Biogen, 5, 8, Janssen, 5, 8, Celgene, 5, 8, Eli Lilly, 1, 5, 8, Novartis, 5, 8, Pfizer, 1, 5, 8, UCB Pharma, 5, 8, Sanofi, 5, 8; L. Coates, AbbVie, 2, 5, 8, Celgene, 2, 5, 8, Novartis, 2, 5, 8, Pfizer, 2, 5, 8, Amgen Inc., 5, 8, Gilead, 5, 8, Janssen, 5, 8, UCB Pharma, 5, 8, Eli Lilly, 2, 5, 8, Biogen, 8, Medac, 8, Boehringer Ingelheim, 5, MSD, 5.

To cite this abstract in AMA style:

Hassan N, van Mens L, Kiltz U, Delgado C, Ovseiko P, Gossec L, Coates L. Gender Equity in Academic Rheumatology – Is There a Gender Gap at European Rheumatology Congresses? [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/gender-equity-in-academic-rheumatology-is-there-a-gender-gap-at-european-rheumatology-congresses/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/gender-equity-in-academic-rheumatology-is-there-a-gender-gap-at-european-rheumatology-congresses/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology